| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |